Intraoperative hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer Journal Article


Authors: Oseledchyk, A.; Zivanovic, O.
Article Title: Intraoperative hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer
Abstract: Here we discuss the advantages and pitfalls of HIPEC in advanced ovarian cancer, as well as current data and ongoing prospective trials. © 2015 UBM Medica Healthcare Publications. All rights reserved.
Keywords: cancer chemotherapy; cancer survival; cisplatin; doxorubicin; fluorouracil; drug efficacy; paclitaxel; disease free survival; cancer staging; outcome assessment; cytoreductive surgery; carboplatin; cancer immunotherapy; nephrotoxicity; ovary cancer; cyclophosphamide; irinotecan; folinic acid; cancer infiltration; micrometastasis; toxicity testing; hyperthermic therapy; mitomycin; oxaliplatin; randomized controlled trial (topic); phase 2 clinical trial (topic); phase 3 clinical trial (topic); phase 1 clinical trial (topic); epithelial mesenchymal transition; polyneuropathy; cancer prognosis; human; article; prognostic assessment
Journal Title: Oncology (Norwalk)
Volume: 29
Issue: 9
ISSN: 0890-9091
Publisher: C M P Medica LLC * The Oncology Group  
Date Published: 2015-09-15
Start Page: 695
End Page: 701, 706
Language: English
PROVIDER: scopus
PUBMED: 26384807
DOI/URL:
Notes: Export Date: 2 October 2015 -- Source: Scopus
Citation Impact
MSK Authors
  1. Oliver Zivanovic
    291 Zivanovic